Matches in Wikidata for { <http://www.wikidata.org/entity/Q86255583> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q86255583 description "clinical trial" @default.
- Q86255583 description "ensayu clínicu" @default.
- Q86255583 description "klinisch onderzoek" @default.
- Q86255583 description "клінічне випробування" @default.
- Q86255583 name "Secukinumab for the Inflammatory Phase of Pyoderma Gangrenosum" @default.
- Q86255583 name "Secukinumab for the Inflammatory Phase of Pyoderma Gangrenosum" @default.
- Q86255583 type Item @default.
- Q86255583 label "Secukinumab for the Inflammatory Phase of Pyoderma Gangrenosum" @default.
- Q86255583 label "Secukinumab for the Inflammatory Phase of Pyoderma Gangrenosum" @default.
- Q86255583 prefLabel "Secukinumab for the Inflammatory Phase of Pyoderma Gangrenosum" @default.
- Q86255583 prefLabel "Secukinumab for the Inflammatory Phase of Pyoderma Gangrenosum" @default.
- Q86255583 P1050 Q86255583-527C1A33-F88F-491E-BFC8-2430495AEF27 @default.
- Q86255583 P1050 Q86255583-9D607C0F-2D9E-4A9D-8B8A-B4B3148F490E @default.
- Q86255583 P1132 Q86255583-2EF0AACF-E34F-4D12-9CAD-2772533CE623 @default.
- Q86255583 P1476 Q86255583-CCF50ABA-46A1-4593-90B3-DF01974101F8 @default.
- Q86255583 P17 Q86255583-F2DE4E59-CBE9-46C4-B17C-C3C5C8D5E5EC @default.
- Q86255583 P2899 Q86255583-74FE8D5F-D7AA-4C9C-B6F6-A578D9309400 @default.
- Q86255583 P3098 Q86255583-B90D4F5E-1C2E-4FDF-A606-56471122D6A6 @default.
- Q86255583 P31 Q86255583-9D711CFA-55C6-4F8A-99E2-0B95E7669BEE @default.
- Q86255583 P4135 Q86255583-9BC3E598-8020-4F60-9432-ED61715967F2 @default.
- Q86255583 P580 Q86255583-4AA9AB8B-00F0-4235-A960-65F9B967AA0F @default.
- Q86255583 P582 Q86255583-265E4F4A-0CD3-47C1-BB37-5885ED3E9962 @default.
- Q86255583 P6099 Q86255583-C736163B-BC40-46EC-8A00-473E34BAE6AC @default.
- Q86255583 P767 Q86255583-7F624613-3481-4EA5-A0FB-C24C8DA98BFC @default.
- Q86255583 P8363 Q86255583-6E3BE62A-C8DA-4CFA-BF6F-B20613FAD91B @default.
- Q86255583 P1050 Q1526459 @default.
- Q86255583 P1050 Q2119633 @default.
- Q86255583 P1132 "+6" @default.
- Q86255583 P1476 "The Efficacy and Safety of Secukinumab for the Inflammatory Phase of Pyoderma Gangrenosum" @default.
- Q86255583 P17 Q30 @default.
- Q86255583 P2899 "+18" @default.
- Q86255583 P3098 "NCT04274166" @default.
- Q86255583 P31 Q30612 @default.
- Q86255583 P4135 "+75" @default.
- Q86255583 P580 "2020-03-01T00:00:00Z" @default.
- Q86255583 P582 "2021-02-28T00:00:00Z" @default.
- Q86255583 P6099 Q42824440 @default.
- Q86255583 P767 Q507154 @default.
- Q86255583 P8363 Q78089383 @default.